CASE COMMENTS : MERGERS – FRANCE – JUDICIAL REVIEW

Jurisdiction of the French Competition Authority : The French Supreme Administrative Court dismisses an action for annulment of two decisions of the French Competition Authority related to the acquisition of two medical laboratories (Eurofins/Bio-Access, Bio-Alfras)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Within a few months, the Eurofins Group, active in the management of analytical, testing and technical inspection laboratories for private companies and public bodies, acquired sole control of the Bio-Access Group and later the Biomnis Group, two groups of laboratories specialising in medical biology. These two transactions were notified to the Competition Authority and authorised after a phase 1 without commitment. Reminder of contested decisions The acquisition of sole control, through the acquisition of a majority stake, of Bio-Access, a group active in the supply of so-called "routine" medical biological analyses, was approved by the Competition

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Herbert Smith Freehills (Paris)
  • Herbert Smith Freehills (Paris)

Quotation

Sergio Sorinas, Marie Louvet, Jurisdiction of the French Competition Authority : The French Supreme Administrative Court dismisses an action for annulment of two decisions of the French Competition Authority related to the acquisition of two medical laboratories (Eurofins/Bio-Access, Bio-Alfras), 21 October 2016, Concurrences N° 1-2017, Art. N° 83477, pp. 142-143

Visites 151

All reviews